Cell Regeneration Technology
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
271
NCT03881267
SkinTE® in the Treatment of Venous Leg Wounds
Phase: N/A
Role: Lead Sponsor
Start: Mar 29, 2019
Completion: Mar 23, 2021
NCT03881254
SkinTE™ in the Treatment of Diabetic Foot Wounds
Start: Apr 2, 2019
Completion: Jul 28, 2021
NCT05372809
Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs
Phase: Phase 3
Start: Apr 28, 2022
Completion: Feb 21, 2024
NCT06140303
SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)
Start: Feb 22, 2024
Completion: Mar 31, 2026
Loading map...